Bill Commons

TX HB 1639

enacted

Relating to a study on the increased incidence of cancer in female firefighters in this state.

Texas · 89th Legislature (2025 Regular Session) · lower

Quick answers

Did TX HB 1639 pass?

Yes. TX HB 1639 has been enacted into law as of 2025-06-20. Latest recorded action (2025-06-20): Effective on 9/1/25

What is TX HB 1639 about?

TX HB 1639 is a bill in the 89th Legislature (2025 Regular Session) titled “Relating to a study on the increased incidence of cancer in female firefighters in this state.”.

Who sponsors TX HB 1639?

Patterson, Collier, Alvarado are the primary sponsors of TX HB 1639, joined by 6 cosponsors.

Introduced
2025-03-12
Latest action
2025-06-20 — Effective on 9/1/25
Bill type
bill
Last updated

Subjects

Sponsors

  • Pattersonprimary
  • Collierprimary
  • Alvaradoprimary
  • Morales Shawcosponsor
  • Parkercosponsor
  • Blancocosponsor
  • Hagenbuchcosponsor
  • Hinojosa, Juan "Chuy"cosponsor
  • Metcalfcosponsor

Committees

Not provided by source.

Action timeline

  1. 2024-12-16

    Filed

    filing

  2. 2025-03-12

    Read first time

    introduction,reading-1

  3. 2025-03-12

    Referred to Public Health

    referral-committee

  4. 2025-04-14

    Considered in public hearing

  5. 2025-04-14

    Testimony taken/registration(s) recorded in committee

  6. 2025-04-14

    Left pending in committee

  7. 2025-04-17

    Considered in formal meeting

  8. 2025-04-17

    Reported favorably w/o amendment(s)

    committee-passage,committee-passage-favorable

  9. 2025-04-21

    Considered in public hearing

  10. 2025-04-21

    Vote reconsidered in committee

  11. 2025-04-21

    Recommended to be sent to Local & Consent

    referral-committee

  12. 2025-04-21

    Reported favorably w/o amendment(s)

    committee-passage,committee-passage-favorable

  13. 2025-04-28

    Comte report filed with Committee Coordinator

    filing

  14. 2025-04-28

    Committee report distributed

  15. 2025-04-28

    Comm. report sent to Local & Consent Calendar

  16. 2025-05-05

    Considered in Local & Consent Calendars

  17. 2025-05-07

    Placed on Local, Consent, and Res. Calendar

  18. 2025-05-07

    Read 2nd time

    reading-2

  19. 2025-05-07

    Passed to engrossment

  20. 2025-05-07

    Nonrecord vote recorded in Journal

  21. 2025-05-07

    Read 3rd time

    reading-3

  22. 2025-05-07

    Passed

    passage

  23. 2025-05-07

    Record vote

  24. 2025-05-07

    Nonrecord vote recorded in Journal

  25. 2025-05-07

    Reported engrossed

  26. 2025-05-08

    Received from the House

    introduction

  27. 2025-05-08

    Read first time

    introduction,reading-1

  28. 2025-05-08

    Referred to Health & Human Services

    referral-committee

  29. 2025-05-14

    Scheduled for public hearing on . . .

  30. 2025-05-14

    Considered in public hearing

  31. 2025-05-14

    Testimony taken in committee

  32. 2025-05-14

    Left pending in committee

  33. 2025-05-15

    Considered in public hearing

  34. 2025-05-15

    Vote taken in committee

  35. 2025-05-19

    Co-sponsor authorized

  36. 2025-05-19

    Reported favorably w/o amendments

    committee-passage-favorable

  37. 2025-05-19

    Committee report printed and distributed

  38. 2025-05-20

    Co-sponsor authorized

  39. 2025-05-20

    Placed on intent calendar

  40. 2025-05-20

    Rules suspended-Intent Calendar

  41. 2025-05-20

    Rules suspended-Regular order of business

  42. 2025-05-20

    Vote recorded in Journal

  43. 2025-05-20

    Read 2nd time & passed to 3rd reading

    reading-2

  44. 2025-05-20

    Vote recorded in Journal

  45. 2025-05-20

    Three day rule suspended

  46. 2025-05-20

    Record vote

  47. 2025-05-20

    Read 3rd time

    reading-3

  48. 2025-05-20

    Passed

    passage

  49. 2025-05-20

    Record vote

  50. 2025-05-20

    Senate passage reported

    passage

  51. 2025-05-20

    Reported enrolled

    enrolled

  52. 2025-05-21

    Signed in the House

    passage

  53. 2025-05-21

    Signed in the Senate

    passage

  54. 2025-05-22

    Sent to the Governor

    executive-receipt

  55. 2025-06-20

    Signed by the Governor

    executive-signature

  56. 2025-06-20

    Effective on 9/1/25

    became-law

Versions

Documents

Votes

  • passage

    2025-05-07 · pass · 141-7

    Member-level votes (8)
    • Cain: no
    • Cook: no
    • Cunningham: no
    • Harrison: no
    • Noble: no
    • Oliverson: no
    • Vasut: no
    • Virdell: no
  • Senate Rule 7.18 and the Constitutional Rule requiring bills to be read on three several days be suspended and that HB 1639 be placed on its third reading and final passage.

    2025-05-20 · pass · 28-3

    Member-level votes (31)
    • Alvarado: yes
    • Bettencourt: yes
    • Birdwell: yes
    • Blanco: yes
    • Campbell: yes
    • Cook: yes
    • Creighton: yes
    • Eckhardt: yes
    • Flores: yes
    • Gutierrez: yes
    • Hagenbuch: yes
    • Hancock: yes
    • A. Hinojosa: yes
    • J. Hinojosa: yes
    • Huffman: yes
    • Johnson: yes
    • King: yes
    • Kolkhorst: yes
    • Menéndez: yes
    • Middleton: yes
    • Miles: yes
    • Nichols: yes
    • Parker: yes
    • Paxton: yes
    • Perry: yes
    • Sparks: yes
    • West: yes
    • Zaffirini: yes
    • Hall: no
    • Hughes: no
    • Schwertner: no

Related bills

No related bills recorded for this bill.

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:33:51.767464Z

Inspect retained evidence for changes recorded after evidence tracking began:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=TX&identifier=HB 1639. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.
  • Some documents have no extracted text yet, so version comparison may be limited.

See the methodology page for data sources and limitations.